Provider QP24-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective June 1, 2021 Read More
Provider QP31-21 Update for New to Market Medical Drugs: Avalglucosidase Alfa and Selexipag (Uptravi intravenous formulation) Read More
Provider QP28-21 Commercial Pharmacy Benefit Exclusion for Select Medications and Formulary Alternatives Read More
Provider P5R2-21 New Reimbursement Policy: Outpatient Services Prior to an Inpatient Admission Read More
